Advertisement
News
Subscribe to MDT Magazine News

Pioneer® Surgical Announces New International Sales V.P.

March 3, 2011 6:38 am | by Bio-Medicine.Org | Comments

MARQUETTE, Mich., March 3, 2011 /- Tom McLeer, GM of Spine and Chief Marketing Officer for Pioneer Surgical, with corporate headquarters located in Marquette, MI, announces the appointment of Jim St. John to the position of Vice President International Sales. Jim has 25 years of...

TOPICS:

Masimo to Present at the Roth Growth Stock Conference

March 3, 2011 6:35 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., March 3, 2011 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Roth 23rd Annual Growth Stock Conference at the Ritz-Carlton in Laguna Niguel, Calif. on Tuesday, March 15, 2011, at 9:00 a.m. P.T.  A live audiocast of the...

TOPICS:

Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study

March 3, 2011 6:35 am | by Bio-Medicine.Org | Comments

FORT WORTH, Texas, March 3, 2011 /PRNewswire-USNewswire/ -- A new report released by the UNT Health Science Center shows that residents of 12 counties in East Texas are breathing a little easier due in part to a year-long education campaign conducted by the health science center's Center...

TOPICS:
Advertisement

Cornerstone Therapeutics profit falls on expenses

March 3, 2011 5:45 am | by The Associated Press | Comments

Cornerstone Therapeutics Inc. said Thursday its fourth-quarter profit fell on higher general and administrative costs because of co-promotion expenses for several drugs.The company earned $792,000, or 3 cents per share, compared with profit of $2.7 million, or 10 cents per share, a year ago....

OraSure, Roche get FDA clearance for drug tests

March 3, 2011 4:45 am | by The Associated Press | Comments

OraSure Technologies Inc. and partner Roche said Thursday the Food and Drug Administration cleared the companies' drug tests for use with the Intercept drug testing system.The approved oral tests seek to find traces of abuse for drugs including cocaine, opiates and methamphetamine. OraSure...

Syneron Named to MDB Capital Group's "Best & Brightest" List

March 3, 2011 4:45 am | by The Associated Press | Comments

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that it has been included in MDB Capital Group's "Best & Brightest" list of 150 innovative leaders for 2011.MDB's Best & Brightest list is drawn from the universe of public companies with at...

FCC Approval of Finite Element Method for Biomedical Transmitters Puts ANSYS Software in the Spotlight

March 3, 2011 4:37 am | by Bio-Medicine.Org | Comments

PITTSBURGH, March 3, 2011 /- For specific electromagnetic applications in the healthcare industry, HFSS™ software from ANSYS (Nasdaq: ANSS ) can now provide proof that a biomedical device transmitter design meets Federal Communications Commission (FCC) standards -- a ruling that...

TOPICS:

Zimmer Holdings to Present at Barclays Capital 2011 Global Healthcare Conference

March 3, 2011 4:37 am | by Bio-Medicine.Org | Comments

WARSAW, Ind., March 3, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the Barclays Capital 2011 Global Healthcare Conference in Miami, Florida, on March 15, 2011, at 8:00 a.m. Eastern Time. A live...

TOPICS:
Advertisement

Cempra Expands Clinical Management Team to Advance Leading Antibacterial Clinical Programs Solithromycin and TAKSTAâ„¢

March 3, 2011 4:37 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., March 3, 2011 /- Cempra Pharmaceuticals today announced the appointment of David Oldach, M.D. as vice president, clinical research as well as announcing an expansion of its clinical development team to manage the company's leading clinical programs, solithromycin and...

TOPICS:

Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACEâ„¢ in the Cystic Fibrosis Pseudomonas Indication

March 3, 2011 4:36 am | by Bio-Medicine.Org | Comments

RICHMOND, Va., March 3, 2011 /- Insmed Incorporated (Nasdaq: INSM ), a biopharmaceutical company, announced today that the Pediatric Committee of the European Medicines Agency (EMA) has issued a positive opinion on the Company's Pediatric Investigation Plan (PIP) for ARIKACE™...

TOPICS:

Ventus Medical Receives CE Mark for Provent® Sleep Apnea Therapy

March 3, 2011 4:36 am | by Bio-Medicine.Org | Comments

BELMONT, Calif., March 3, 2011 /- Ventus Medical, Inc. a privately-held medical device company dedicated to providing novel products to treat sleep-disordered breathing, today announced that it has received CE Mark for its Provent® Sleep Apnea Therapy. (Photo:  ...

TOPICS:

Dehaier Medical to Report Fourth Quarter and Full-Year 2010 Financial Results on March 7

March 3, 2011 4:36 am | by Bio-Medicine.Org | Comments

BEIJING, March 3, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

TOPICS:

JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome

March 3, 2011 4:36 am | by Bio-Medicine.Org | Comments

NEW HAVEN, Conn., March 3, 2011 /- The launch of a new, non-invasive test for the identification of Turner syndrome (TS) was announced today by JS Genetics.  The test, XCAT-TS, is a simple cheek swab that identifies girls with Turner syndrome. Until now, Turner syndrome could only be...

TOPICS:

Varian Medical Systems to Showcase New X-Ray Tubes and Flat Panel Detectors at the ECR Annual Meeting

March 3, 2011 4:35 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, March 3, 2011 /- ECR Booth #313/Expo C - Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the...

TOPICS:

Demand pressurises super junction MOSFET producers

March 3, 2011 3:37 am | by I-Micronews | Comments

Super junction MOS FET manufacturers are evolving their strategies after rapid growth in interest in 2010 and with further applications set to take off, Andy Extance finds.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading